Skip to content

Ferric maltol

Accrufer, Feraccru (ferric maltol) is a small molecule pharmaceutical. Ferric maltol was first approved as Accrufer on 2016-02-18. It has been approved in Europe to treat iron-deficiency anemia. Accrufer's patent is valid until 2035-10-23 (FDA).
Trade Name Feraccru
Common Name Ferric maltol
Indication iron-deficiency anemia
Drug Class Hematologic agents
Ferric maltol
Get full access now